Cytochrome P450 4B1 (CYP4B1) as a target in cancer treatment

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Cytochrome P450 4B1 (CYP4B1) is crucial for xenobiotic metabolism, with predominant extrahepatic expression linked to tissue-specific toxicities.
• The role of CYP4B1 in various cancers and its involvement in cancer development remain incompletely understood.
• CYP4B1 exhibits wide tissue distribution, with lungs being a primary site, and its gene expression is potentially regulated by nuclear receptors.

Purpose of the Study:

• To review existing knowledge on CYP4B1 expression, regulation, and catalysis.
• To examine the association of CYP4B1 with cancer, including contradictory findings on human activity.
• To evaluate the potential of CYP4B1 in a suicide gene approach for cancer treatment.

Main Methods:

• Literature review of CYP4B1 gene and protein expression, regulation, and catalytic activity.
• Analysis of CYP4B1's involvement in cancer through procarcinogen activation and neovascularization.
• Review of studies employing CYP4B1 in suicide gene therapy for cancer.

Main Results:

• CYP4B1 is predominantly expressed in the lungs and its expression may be regulated by nuclear receptors.
• CYP4B1's role in cancer involves procarcinogen activation and neovascularization.
• Human CYP4B1 exhibits inactivity due to a Pro427Ser substitution, but a reengineered CYP4B1 combined with 4-ipomeanol (4-IPO) shows potential in suicide gene therapy.

Conclusions:

• Further research is needed to verify human CYP4B1 catalytic activities.
• The reengineered CYP4B1 and 4-IPO suicide gene system presents a promising avenue for targeted cancer therapy.
• Exploring alternative agents structurally similar to 4-IPO is crucial for advancing this therapeutic approach.